Literature DB >> 11262608

Altered gene expression in lymphocytes of patients with normal-tension glaucoma.

O Golubnitschaja-Labudova1, R Liu, C Decker, P Zhu, I O Haefliger, J Flammer.   

Abstract

BACKGROUND: In glaucoma there is a loss of retinal ganglion cells. There is evidence that this loss can occur by apoptosis. The signal transduction leading to retinal ganglion cell apoptosis in glaucoma is not yet clear. The present study compares the gene expression in lymphocytes of normal tension glaucoma patients (NTG-patients) with the one of healthy controls.
METHODS: Subtractive hybridization was used to compare mRNA in lymphocytes of six vasospastic NTG-patients with six age and sex matched healthy subjects.
RESULTS: Genes coding for p53-protein, NTP (neural thread protein) and 20 S proteasome subunit XAPC7 were overexpressed, whereas those coding for XPGC (Xeroderma pigmentosum gene), the survivin protein as well as one type of ABC transport protein were underexpressed.
CONCLUSION: In comparison to healthy controls, patients with vasospastic NTG seem to over- as well as under-express certain genes in their lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11262608     DOI: 10.1076/ceyr.21.5.867.5534

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  18 in total

1.  Matrix metalloproteinase 9 expression: new regulatory elements.

Authors:  Irina Surgucheva; Kumaravel Chidambaram; David A Willoughby; Andrei Surguchov
Journal:  J Ocul Biol Dis Infor       Date:  2010-08-05

2.  Effect of gamma-synuclein silencing on apoptotic pathways in retinal ganglion cells.

Authors:  Irina Surgucheva; Valery I Shestopalov; Andrei Surguchov
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

3.  Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach.

Authors:  Olga Golubnitschaja; Jiri Polivka; Kristina Yeghiazaryan; Leonard Berliner
Journal:  EPMA J       Date:  2018-08-17       Impact factor: 6.543

4.  Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care.

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Melanie Cebioglu; Micaela Morelli; Mario Herrera-Marschitz
Journal:  EPMA J       Date:  2011-06-09       Impact factor: 6.543

Review 5.  Current concepts in the pathophysiology of glaucoma.

Authors:  Renu Agarwal; Suresh K Gupta; Puneet Agarwal; Rohit Saxena; Shyam S Agrawal
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

6.  Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Selim Orgül; Kerstin Wunderlich; Olga Golubnitschaja
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

7.  Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.

Authors:  Holger Fröhlich; Sabyasachi Patjoshi; Kristina Yeghiazaryan; Christina Kehrer; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-04-11       Impact factor: 6.543

Review 8.  The eye and the heart.

Authors:  Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

9.  Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Josef Flammer
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

10.  The p53 codon 72 PRO/PRO genotype may be associated with initial central visual field defects in caucasians with primary open angle glaucoma.

Authors:  Janey L Wiggs; Alex W Hewitt; Bao Jian Fan; Dan Yi Wang; Dayse R Figueiredo Sena; Colm O'Brien; Anthony Realini; Jamie E Craig; David P Dimasi; David A Mackey; Jonathan L Haines; Louis R Pasquale
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.